Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cedars-Sinai Intellectual Property Company (CSIP Co.) is the technology transfer and commercialization arm of Cedars-Sinai. It manages intellectual property generated by faculty and partners, oversees venture investments in healthcare/life sciences startups globally, executes licenses (over 100), holds more than 1,200 patents covering medical technologies, has spun out numerous companies (e.g., Prometheus Biosciences), and generated over $1 billion in income from commercialization efforts. Its activities support research funding at Cedars-Sinai while advancing innovations into clinical use[1][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cedars-Sinai Intellectual Property Company.